SOURCE: Thomas Weisel Partners Group, Inc.

September 05, 2007 11:50 ET

Thomas Weisel Partners Hosts Annual Healthcare Conference

Investment Conference Will Focus on Healthcare Trends

BOSTON, MA--(Marketwire - September 5, 2007) - Thomas Weisel Partners (NASDAQ: TWPG), an investment bank focused on the growth sectors of the economy, will host its Annual Healthcare Conference, September 5-7, 2007 at the Four Seasons Hotel in Boston. Institutional investors and top management from over 150 healthcare companies will gather for the three-day investment conference to discuss recent trends in healthcare.

Participating sectors represented at the conference include Applied Technologies, Biopharmaceuticals, Biotechnology, Diagnostics, Healthcare Information Technology, Life Science Technology, Medical Devices, Pharmaceutical Services and Specialty Pharmaceuticals.

Showcased at our event will be first-class talent such as William A. Hawkins, President and Chief Executive Officer of Medtronic, and James Surowiecki, Author of "The Wisdom of Crowds." A full list of company participants follows:

Accelrys, Inc.
ADVENTRX Pharmaceuticals, Inc.
Affymax, Inc.
Affymetrix, Inc.
AGA Medical Corporation
AgaMatrix, Inc.
Agilent Technologies, Inc.
Alkermes, Inc.
Allion Healthcare, Inc.
Allscripts Healthcare Solutions, Inc.
American Medical Systems, Inc.
AMICAS, Inc.
Amylin Pharmaceuticals, Inc.
Applied Biosystems Group
Array BioPharma Inc.
Asuragen, Inc.
AtriCure, Inc.
Atritech, Inc.
ATS Medical, Inc.
Auxilium Pharmaceuticals, Inc.
Axcan Pharma Inc.
BåRRX Medical, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Biogen Idec Inc.
Caliper Life Sciences, Inc.
Celera
Celgene Corporation
Cephalon, Inc.
Cepheid
Cerner Corporation
Charles River Laboratories International, Inc.
CollaGenex Pharmaceuticals, Inc.
CombinatoRx, Incorporated
Covance Inc.
Cubist Pharmaceuticals, Inc.
CVRx, Inc.
CVS Caremark Corporation
Cytyc Corporation
deCODE genetics, Inc.
Depomed, Inc.
diaDexus, Inc.
Dionex Corporation
Disc Dynamics, Inc.
Eclipsys Corporation
eHealth, Inc.
Emageon Inc.
Emergent BioSolutions Inc.
EPIX Pharmaceuticals, Inc.
eResearchTechnology, Inc
Eurand N.V.
ev3 Inc.
Gen-Probe Incorporated
Genentech, Inc.
Genzyme Corporation
Gilead Sciences, Inc.
Hansen Medical, Inc.
Harvard Bioscience, Inc.
HMS Holdings Corp.
Human Genome Sciences, Inc.
Illumina Inc.
Immucor, Inc
IMS Health Incorporated
Inovio Biomedical Corporation
Inspire Pharmaceuticals, Inc.
Insulet Corporation
InterMune, Inc.
Introgen Therapeutics, Inc
Intuitive Surgical, Inc.
ISTA Pharmaceuticals, Inc.
Kendle International Inc.
King Pharmaceuticals, Inc.
LeMaitre Vascular, Inc.
Lifecore Biomedical, Inc.
Ligand Pharmaceuticals Inc.
Light Sciences Oncology Inc.
Lincare Holdings Inc.
Luminex Corporation
Magellan Biosciences, Inc.
McKesson Corporation
MDS Inc.
Medarex, Inc.
Medco Health Solutions, Inc.
Medicis
Medtronic, Inc.
Merit Medical Systems, Inc
Metabasis Therapeutics, Inc.
Metabolix, Inc.
Mettler-Toledo International, Inc.
Millennium Pharmaceuticals Inc.
Monogram Biosciences, Inc.
Nabi Biopharmaceuticals
Nanogen, Inc.
Natus Medical Incorporated
Neurocrine Biosciences, Inc.
Neuronetics, Inc.
NightHawk Radiology Holdings, Inc.
NitroMed, Inc.
Northfield Laboratories, Inc.
Novadaq Technologies Inc.
Noven Pharmaceuticals, Inc.
NuVasive, Inc.
NxStage Medical, Inc.
Obagi Medical Products, Inc.
Omnicare, Inc.
Omnicell, Inc.
Orthofix International N.V.
Osiris Therapeutics, Inc.
PAREXEL International Corporation
PerkinElmer, Inc.
Pharmaceutical Product Development, Inc.
Pharmaxis Ltd.
Phase Forward Incorporated
Picis, Inc.
Poniard Pharmaceuticals Inc.
Progen Pharmaceuticals Limited
Qiagen N.V.
Quality Systems, Inc.
RadNet Inc.
Rib-X Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.
Salix Pharmaceuticals, Ltd.
Santarus, Inc.
Sciele Pharma, Inc.
Sepracor, Inc.
SkinMedica, Inc.
Stericycle, Inc.
STERIS Corporation
Stryker Corporation
SuperGen, Inc.
Symmetry Medical Inc.
Symyx Technologies, Inc.
Syneron Medical Ltd.
The Trizetto Group, Inc.
Theravance, Inc.
Thermage, Inc.
Thermo Fisher Scientific Inc.
Third Wave Technologies, Inc.
Thoratec Corporation
TissueLink Medical, Inc.
TomoTherapy Incorporated
Transcept Pharmaceuticals, Inc.
Trinity Biotech plc
ULURU Inc.
Varian, Inc.
Ventana Medical Systems, Inc.
ViroPharma Incorporated
Visicu, Inc.
Vital Images, Inc.
Vital Signs, Inc.
Wright Medical Group, Inc.
Xoft Inc.
Zimmer Holdings, Inc.

Thomas Weisel Partners Group, Inc. is an investment bank focused principally on the technology, healthcare and consumer sectors of the economy. Founded in 1998, the firm's business includes investment banking, brokerage, equity research and asset management services. Thomas Weisel Partners is headquartered in San Francisco, California with additional offices in New York City, Boston, Silicon Valley, Portland, Chicago, Cleveland, London and Mumbai, India.